MONOVALENT TYPE 1
ORAL POLIOVIRUS VACCINES IN NEWBORNS.
Change and challenge is in the wind as 2008 comes to an
end. The same is true when examining this month’s ReachMD XM160 special series
focus on global medicine. We take a look at both the changes and the
challenges impacting global medicine.
The World Health Organization is working diligently to
eliminate type 1 poliovirus transmission in endemic countries around the
world. Although, progress has been made using the trivalent oral poliovirus
vaccine, eradication remains elusive. Recent studies examined the efficacy of
a monovalent oral polio vaccine given to newborn. Could this monovalent vaccine
bring us closer to eradicating poliomyelitis? You are listening to ReachMD,
The Channel for Medical Professionals. Welcome to a special segment focused on
global medicine. I am your host, Dr. Jennifer Shu practicing general
pediatrician and author. Our guest is Dr. Roland Sutter, coordinator of the
research and product development team for the Global Polio Eradication
Initiative with the World Health Organization in Geneva, Switzerland and former
chief of the polio eradication branch at the Centers for Disease Control and
Prevention in Atlanta.
DR. JENNIFER SHU:
Welcome, Dr. Sutter.
DR. ROLAND SUTTER:
DR. ROLAND SUTTER:
DR. ROLAND SUTTER: